Composition of Cidaflox Clav Tablets Each film coated dispersible tablet contains: Cefpodoximeproxetil IP equivalent to anhydrous Cefpodoxime 200 mg Potassium Clavulanate diluted IP equivalent to Clavulanic Acid 125 mg
Indications of Cidaflox Clav Tablets Switch therapy Community Acquired Pneumonia Acute exacerbation of Chronic Bronchitis (AECB) Respiratory tract infections Acute Otitis Media Pharyngitis Tonsillitis
Dosage of Cidaflox Clav Tablets One tablet BID OR as directed by the Physician. Form: Tablets Pack: 10 x 6s